(d-Met2,Pro5)Enkephalinamide causes a decrease in plasma prolactin levels of lactating rats continuously suckled and an increase in those deprived of their litter
- 1 July 1984
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 8 (4) , 321-326
- https://doi.org/10.1016/0167-0115(84)90042-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- An inhibitory role for morphine on the release of dopamine into hypophysial portal blood and on the synthesis of dopamine in tuberoinfundibular neuronsBrain Research, 1983
- Morphine- and opioid peptide-induced inhibition of the release of dopamine from tuberoinfundibular neuronsLife Sciences, 1979
- Involvement of Brain Serotonin in the Prolactin- Releasing Effect of Opioid Peptides*Endocrinology, 1979
- Interaction between opiates and hypothalamic dopamine on prolactin releaseLife Sciences, 1979
- Relation of endogenous opioid peptides and morphine to neuroendocrine functionsLife Sciences, 1979
- Evidence for a role of endorphins in stress- and suckling-induced prolactin release in the ratMolecular and Cellular Endocrinology, 1978
- Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administrationCellular and Molecular Life Sciences, 1978
- Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin - evidence for regulation by an endogenous opioid peptide in brainLife Sciences, 1977
- Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormoneLife Sciences, 1977
- A superactive antinociceptive pentapeptide, (D‐Met2,Pro5)‐enkephalinamideFEBS Letters, 1977